NCT00108810View on ClinicalTrials.gov

Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
PainOsteoarthritis, Knee
Interventions
DRUG

Transdermal Ketoprofen Patch with CHADD

12 hours patch application for 28 days

DRUG

Placebo transdermal patch

12 hours application for 28 days

Trial Locations (5)

10021

Hospital for Special Surgery, New York

20006

The Center for Rheumatology and Bone Research, Washington D.C.

32114

Radiant Research, Daytona Beach

33024

University Clinical Research, Pembroke Pines

90620

SouthBay Pharma Research, Buena Park

All Listed Sponsors
lead

ZARS Pharma Inc.

INDUSTRY

NCT00108810 - Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee | Biotech Hunter | Biotech Hunter